Pharmaceutical - Markets & Marketing, Mergers & Acquisitions


Popular Filters

Global oncology market to hit $109 billion in 2020

Global oncology market to hit $109 billion in 2020


Cancer, with a death toll exceeding that of AIDS (acquired immune deficiency syndrome), tuberculosis…

AvastinCelgene Corp.GlobalMarkets & MarketingMergers & AcquisitionsNovartisOncologyPharmaceuticalResearchRevlimidRoche

GlaxoSmithKline takes stake in new Aspen Japanese unit

GlaxoSmithKline takes stake in new Aspen Japanese unit


South African drugmaker Aspen Pharmacare says that Aspen Global Inc, a subsidiary of Aspen Holdings,…

Aspen PharmacareGlaxoSmithKlineJapanMarkets & MarketingMergers & AcquisitionsPharmaceutical

Walgreens to buy remainder of Boots Alliance, but shuns inversion


US pharmacy giant Walgreen has exercised its option to buy the remaining 55% of European pharmacy retailer…

Alliance BootsEuropeMarkets & MarketingMergers & AcquisitionsPharmaceuticalWalgreens

Growing Indian pharma market provides incentives for foreign acquisitions


A recent IMS Institute for Healthcare Informatics global study has revealed that greater access to medicines…

Asia-PacificIndiaMarkets & MarketingMergers & AcquisitionsPharmaceutical

Report: M&A worth $11 billion in third quarter while Russian market shows promise

Report: M&A worth $11 billion in third quarter while Russian market shows promise


PricewaterhouseCoopers (PwC) has released its quarterly Life Sciences Deals Insights Quarterly for the…

BiotechnologyEuropeMarkets & MarketingMergers & AcquisitionsPharmaceutical

Alliance Boots and Walgreens expansion into China an "obvious next step," says EIU analyst


Following the news that Alliance Boots and the USA's Walgreen, which initially took a 45% stake in the…

Alliance BootsAsia-PacificMarkets & MarketingMergers & AcquisitionsPharmaceuticalWalgreens

ISTA Pharma pleads guilty to federal felony charges in $33.5 million settlement; parent Bausch & Lomb a Valeant takeover target?


US drugmaker ISTA Pharmaceuticals has pleaded guilty to conspiracy to introduce a misbranded drug into…

Bausch & LombISTA PharmaceuticalLegalMarkets & MarketingMergers & AcquisitionsNorth AmericaPharmaceuticalValeant PharmaceuticalsXibrom

Alliance Boots to build up interest in China


According to the Financial Times, Stefano Pessina, executive chairman of Alliance Boots, is looking to…

Alliance BootsAsia-PacificMarkets & MarketingMergers & AcquisitionsPharmaceuticalWalgreens

OPKO Health acquires 10% stake in Russia's Pharmsynthez


USA-based OPKO Health (NYSE: OPK) says it has acquired an approximate 10% stake in OAO Pharmsynthez (MICEX:…

EuropeLicensingMarkets & MarketingMergers & AcquisitionsOPKO HealthPharmaceuticalPharmsynthez

Analysis of China government incentives for pharma


China remains an attractive target for pharmaceutical research and manufacturing, and major players from…

Asia-PacificLicensingMarkets & MarketingMergers & AcquisitionsPatentsPharmaceutical

Aggressive strategies confirm Big Pharma's Indian interest


The increasing number of consolidations and in-licensing agreements between multinational corporations…

Asia-PacificLicensingMarkets & MarketingMergers & AcquisitionsPharmaceutical

Norgine and SpePharm set up JV to commercialize portfolio of drugs


Independent Dutch firm Norgine BV and fellow Amsterdam-based SpePharm Holding BV have concluded a broad…

Markets & MarketingMergers & AcquisitionsNorginePharmaceuticalSpePharma

India's Elder Pharma to enter EU markets; comment on GSK Indian OTC moves


Indian drugmaker Elder Pharmaceuticals says it is ready to enter the European Union market following…

Asia-PacificdiosminElder PharmaceuticalsEuropeGenericsGlaxoSmithKlineMarkets & MarketingMergers & AcquisitionsPharmaceuticalRegulation

Otsuka Pharma sets up joint venture in Turkey


Otsuka Pharmaceutical (TYO: 4768), a mid-size Japanese drugmaker, and Abdi ����¯�¿�½���¯���¿���½������¯������¿������½����¯�¿�½���¯���¿���½����¯�¿�½������°brahim…

Abdi IbrahimEuropeMarkets & MarketingMergers & AcquisitionsOtsukaPharmaceutical

Analyst insight: Sanofi eyes Columbia, Indonesia and Vietnam


Emerging markets, BRIC countries are words that have recently risen to prominence in a majority of pharmaceutical…

Asia-PacificLicensingMarkets & MarketingMergers & AcquisitionsPharmaceuticalSanofiSouth America

Japan's vulnerable pharma companies, by P Reed Maurer


Once upon a time Japan's pharma companies could be compared to a convoy of ships. The big and small,…

Asia-PacificLicensingManagementMarkets & MarketingMergers & AcquisitionsPharmaceutical

Pharmaceutical supply chain in Japan sees squeezed margins


Pressures felt in Japan as a result of the country's aging population, drug price revisions and patent…

Asia-PacificBiotechnologyFinancialMarkets & MarketingMergers & AcquisitionsPharmaceuticalPricing

Adcock Ingram expands in Indian pharma market buying Cosme Farma brands


South Africa's largest health care company Adcock Ingram (AIP: SJ) says it has reached an agreement to…

Adcock IngramCosme FarmaMarkets & MarketingMergers & AcquisitionsPharmaceutical

Sigma-Aldrich acquires Research Organics; opens new facility in China


USA-headquartered Sigma-Aldrich (Nasdaq: SIAL) has acquired all outstanding shares of Cleveland, Ohio-based,…

Asia-PacificGenericsMarkets & MarketingMergers & AcquisitionsNorth AmericaPharmaceuticalResearch OrganicsSigma-Aldrich

Bayer still aims for top-10 position in Pharma


Germany's Bayer (BAY: DE) is still confident that it can become a top-10 gobal pharmaceutical company,…

Markets & MarketingMergers & AcquisitionsPharmaceuticalResearch

Merck & Co sets up marketing JV in Brazil


Merck & Co (NYSE: MRK) says it has formed a new joint venture with Supera Farma Laboratorios, a Brazilian…

CristaliaEurofarmaGenericsMarkets & MarketingMerck & CoMergers & AcquisitionsPharmaceuticalSouth AmericaSupera Farma

New Actavis/Bioton alliance aims to shake up diabetes market


Icelandic generics drugmaker Actavis and Poland’s Bioton (WSE: BIO) have formed a joint venture…

ActavisBiotonDiabetesGenericsMarkets & MarketingMergers & AcquisitionsPharmaceutical

Shire gets US Rights to Resolor


Ireland-headquartered specialty biopharma firm Shire (LSE: SHP) says that it has acquired the rights…

Gastro-intestinalsMarkets & MarketingMergers & AcquisitionsNorth AmericaPharmaceuticalResolorShire

Back to top